Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Liver International : Official Journal of the International Association for the Study of the Liver|April 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year AnalysisAdrielly Martins, Anish Reddy, Richard Dean, et al.Gastroenterology|May 20, 2015
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T Everson, Steven L Flamm, et al.The New England Journal of Medicine|November 18, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 InfectionGraham R Foster, Nezam Afdhal, Stuart K Roberts, et al.Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.Hepatology (Baltimore, Md.)|October 18, 2021
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitisKunpeng Hu, Maria C Perez-Matos, Josepmaria Argemi, et al.Journal of Gastroenterology and Hepatology|August 14, 2020
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Murat Torgutalp, Ida Henriksson, et al.The American Journal of Gastroenterology|June 27, 2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisCumali Efe, Koray Taşçilar, Ida Henriksson, et al.Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.Journal of Hepatology|July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitisChristophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.Journal of Hepatology|May 31, 2024
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantationAldo J Montano-Loza, Ellina Lytvyak, Gideon Hirschfield, et al.Pageof 16